Matthias Gehringer - Search Results

Year	Number of Results
2013	1
2014	5
2015	4
2016	2
2017	4
2018	2
2019	2
2020	3
2021	5
2022	6
2023	1
2024	4

1

Gehringer M. Gehringer M. Future Med Chem. 2020 Aug;12(15):1363-1368. doi: 10.4155/fmc-2020-0118. Epub 2020 Jun 29. Future Med Chem. 2020. PMID: 32597212 No abstract available.

2

The chemistry and biology of mycolactones.

Gehringer M, Altmann KH. Gehringer M, et al. Beilstein J Org Chem. 2017 Aug 11;13:1596-1660. doi: 10.3762/bjoc.13.159. eCollection 2017. Beilstein J Org Chem. 2017. PMID: 28904608 Free PMC article. Review.

3

Chemical Probes for Understudied Kinases: Challenges and Opportunities.

Serafim RAM, Elkins JM, Zuercher WJ, Laufer SA, Gehringer M. Serafim RAM, et al. Among authors: gehringer m. J Med Chem. 2022 Jan 27;65(2):1132-1170. doi: 10.1021/acs.jmedchem.1c00980. Epub 2021 Sep 3. J Med Chem. 2022. PMID: 34477374 Review.

4

Publication Criteria and Requirements for Studies on Protein Kinase Inhibitors─What Is Expected?

Laufer S, Bajorath J, Gehringer M, Gray N, Frye S, Lindsley CW. Laufer S, et al. Among authors: gehringer m. J Med Chem. 2022 May 26;65(10):6973-6974. doi: 10.1021/acs.jmedchem.2c00623. Epub 2022 May 5. J Med Chem. 2022. PMID: 35512193 No abstract available.

5

Inhibitors of c-Jun N-terminal kinases: an update.

Koch P, Gehringer M, Laufer SA. Koch P, et al. Among authors: gehringer m. J Med Chem. 2015 Jan 8;58(1):72-95. doi: 10.1021/jm501212r. Epub 2014 Dec 8. J Med Chem. 2015. PMID: 25415535 Review.

6

Journal of Medicinal Chemistry Collection: Drug Discovery in Germany.

Laufer S, Gehringer M, Titz A. Laufer S, et al. Among authors: gehringer m. J Med Chem. 2024 Feb 22;67(4):2237. doi: 10.1021/acs.jmedchem.4c00122. Epub 2024 Feb 2. J Med Chem. 2024. PMID: 38305161 No abstract available.

7

Developing Small-Molecule Inhibitors of HECT-Type Ubiquitin Ligases for Therapeutic Applications: Challenges and Opportunities.

Chen D, Gehringer M, Lorenz S. Chen D, et al. Among authors: gehringer m. Chembiochem. 2018 Oct 18;19(20):2123-2135. doi: 10.1002/cbic.201800321. Epub 2018 Oct 17. Chembiochem. 2018. PMID: 30088849 Free PMC article. Review.

8

Targeted Covalent Inhibitors in Drug Discovery, Chemical Biology and Beyond.

Serafim RAM, Gehringer M, Borsari C. Serafim RAM, et al. Among authors: gehringer m. Pharmaceuticals (Basel). 2024 Feb 5;17(2):206. doi: 10.3390/ph17020206. Pharmaceuticals (Basel). 2024. PMID: 38399421 Free PMC article.

9

Frontiers in Medicinal Chemistry 2022 Goes Virtual.

Diamanti E, Méndez M, Ross T, Kuttruff CA, Lefranc J, Klingler FM, von Nussbaum F, Jung M, Gehringer M. Diamanti E, et al. Among authors: gehringer m. ChemMedChem. 2022 Nov 4;17(21):e202200419. doi: 10.1002/cmdc.202200419. Epub 2022 Oct 5. ChemMedChem. 2022. PMID: 36198574

10

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.

Gehringer M, Laufer SA. Gehringer M, et al. J Med Chem. 2019 Jun 27;62(12):5673-5724. doi: 10.1021/acs.jmedchem.8b01153. Epub 2019 Jan 25. J Med Chem. 2019. PMID: 30565923 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year